Holding(s) in Company

RNS Number : 9483B
Phytopharm PLC
04 November 2009
 





TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are

attached:
 ii

Phytopharm plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
 iii

Barclays plc

4. Full name of shareholder(s) 
 (if different from 3.):iv


5. Date of the transaction and date on
which the threshold is crossed or

reached:
 v

27 October 2009

6. Date on which issuer notified:

2 November 2009

7. Threshold(s) that is/are crossed or
reached:
 vi, vii

5% to below notifiable %

  

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the 
triggering
transaction

Resulting situation after the triggering transaction

Number
of

Shares

Number
of

V
oting
Rights

Number
of shares

Number of voting
rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0006869720

4,776,789

4,776,789

Not reportable

Not reportable

Not reportable

Not reportable

Not reportable



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
 xiii

Exercise/ 
Conversion Period xiv

Number of voting
rights that may be

acquired if the

instrument is

exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
 xviii

Number of voting rights instrument refers to


% of voting rights xix, xx








Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

Not reportable

Not reportable

  

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
 xxi



Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:


14. Contact name:

Zoe McGowan

15. Contact telephone number:

01480 437697

  

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share


A: Identity of the persons or legal entity subject to the notification obligation

Full name 

(including legal form of legal entities)



Contact address 

(registered office for legal entities)



Phone number & email



Other useful information 

(at least legal representative for legal persons)





B: Identity of the notifier, if applicable

Full name



Contact address



Phone number & email



Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)



C: Additional information


For notes on how to complete form TR-1 please see the FSA website. 



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLXZLFBKFBXFBB

Companies

Ixico (IXI)
UK 100

Latest directors dealings